Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

Press releases published on September 16, 2026

11 hours ago

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

Indeterminate GlobeNewswire

11 hours ago

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Indeterminate GlobeNewswire

12 hours ago

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®

Indeterminate GlobeNewswire

12 hours ago

Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

Indeterminate GlobeNewswire

12 hours ago

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Indeterminate GlobeNewswire

12 hours ago

Ennature Biopharma Advances Women’s Health Science With Fast-Acting Shatavari and Sustained-Release Ginger

Indeterminate GlobeNewswire

12 hours ago

Coave Therapeutics Strengthens Leadership Team to Advance Lead Gene Therapy Program into the Clinic

Indeterminate GlobeNewswire

12 hours ago

Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration

Indeterminate GlobeNewswire

12 hours ago

Sironax Announces Option Exercise and Asset Purchase

Indeterminate GlobeNewswire

12 hours ago

NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

12 hours ago

Kailera Therapeutics to Participate in September Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026

Indeterminate GlobeNewswire

12 hours ago

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

12 hours ago

Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026

Indeterminate GlobeNewswire

12 hours ago

维泰瑞隆宣布其脑部递送平台收购选择权已获行使并完成交易

Indeterminate GlobeNewswire

12 hours ago

維泰瑞隆宣佈其腦部遞送平臺收購選擇權已獲行使並完成交易

Indeterminate GlobeNewswire

12 hours ago

Grey Matters Announces an Increase to its Equity and Convertible Debenture Private Placement to CAD $1.1 Million

Indeterminate GlobeNewswire

14 hours ago

Abalos Therapeutics Publishes Two Articles in Viruses Further Validating its AdaptInnate Approach to Treat Solid Tumors

Indeterminate GlobeNewswire

15 hours ago

Theolytics to Showcase its Innovative Oncolytic Immunotherapy Strategy – including THEO-260 in Advanced Ovarian Cancer – at Upcoming Investor and Scientific Events

Indeterminate GlobeNewswire

16 hours ago

EIB and Angelini Ventures’ Partnership Reaches €48.5 Million in Investments

Indeterminate GlobeNewswire